Bering Partners II, L.P. ("Bering II") 13D and 13G filings for Coherus Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-04 6:44 pm Purchase | 2025-09-05 | 13G | COHERUS ONCOLOGY, INC. CHRS | Bering Partners II, L.P. ("Bering II") | 7,602,708 6.500% | 7,602,708 (New Position) | Filing |